703 related articles for article (PubMed ID: 16039877)
1. Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients.
Curkendall SM; DeLuise C; Jones JK; Lanes S; Stang MR; Goehring E; She D
Ann Epidemiol; 2006 Jan; 16(1):63-70. PubMed ID: 16039877
[TBL] [Abstract][Full Text] [Related]
2. Rates of hospitalizations and emergency department visits in patients with asthma and chronic obstructive pulmonary disease taking beta-blockers.
Brooks TW; Creekmore FM; Young DC; Asche CV; Oberg B; Samuelson WM
Pharmacotherapy; 2007 May; 27(5):684-90. PubMed ID: 17461703
[TBL] [Abstract][Full Text] [Related]
3. Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older adults.
Blanchette CM; Akazawa M; Dalal A; Simoni-Wastila L
Am J Geriatr Pharmacother; 2008 Aug; 6(3):138-46. PubMed ID: 18775388
[TBL] [Abstract][Full Text] [Related]
4. [Comorbidity in chronic obstructive pulmonary disease].
Karoli NA; Orlova EE; Markova AV; Rebrov AP
Ter Arkh; 2008; 80(3):20-3. PubMed ID: 18441678
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular morbidity associated with nonadherence to statin therapy.
Blackburn DF; Dobson RT; Blackburn JL; Wilson TW
Pharmacotherapy; 2005 Aug; 25(8):1035-43. PubMed ID: 16207093
[TBL] [Abstract][Full Text] [Related]
6. Chronic obstructive pulmonary disease: a novel risk factor for cardiovascular disease.
Sin DD; Man SF
Can J Physiol Pharmacol; 2005 Jan; 83(1):8-13. PubMed ID: 15759045
[TBL] [Abstract][Full Text] [Related]
7. Long-term survival of patients with chronic obstructive pulmonary disease undergoing coronary artery bypass surgery.
Leavitt BJ; Ross CS; Spence B; Surgenor SD; Olmstead EM; Clough RA; Charlesworth DC; Kramer RS; O'Connor GT;
Circulation; 2006 Jul; 114(1 Suppl):I430-4. PubMed ID: 16820614
[TBL] [Abstract][Full Text] [Related]
8. Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease.
Mancini GB; Etminan M; Zhang B; Levesque LE; FitzGerald JM; Brophy JM
J Am Coll Cardiol; 2006 Jun; 47(12):2554-60. PubMed ID: 16781387
[TBL] [Abstract][Full Text] [Related]
9. Mortality-related factors after hospitalization for acute exacerbation of chronic obstructive pulmonary disease: the burden of clinical features.
Bustamante-Fermosel A; De Miguel-Yanes JM; Duffort-Falcó M; Muñoz J
Am J Emerg Med; 2007 Jun; 25(5):515-22. PubMed ID: 17543654
[TBL] [Abstract][Full Text] [Related]
10. Use of beta blockers and the risk of death in hospitalised patients with acute exacerbations of COPD.
Dransfield MT; Rowe SM; Johnson JE; Bailey WC; Gerald LB
Thorax; 2008 Apr; 63(4):301-5. PubMed ID: 17951276
[TBL] [Abstract][Full Text] [Related]
11. Implications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: a community study.
Johannessen A; Omenaas ER; Bakke PS; Gulsvik A
Thorax; 2005 Oct; 60(10):842-7. PubMed ID: 16085729
[TBL] [Abstract][Full Text] [Related]
12. Predictors of hospital admission for chronic obstructive pulmonary disease exacerbations in Canadian emergency departments.
Rowe BH; Villa-Roel C; Guttman A; Ross S; Mackey D; Sivilotti ML; Worster A; Stiell IG; Willis V; Borgundvaag B
Acad Emerg Med; 2009 Apr; 16(4):316-24. PubMed ID: 19298621
[TBL] [Abstract][Full Text] [Related]
13. [Chronic obstructive pulmonary disease and cardiovascular system].
Gürgün A; Gürgün C
Tuberk Toraks; 2008; 56(4):464-71. PubMed ID: 19123087
[TBL] [Abstract][Full Text] [Related]
14. Chronic obstructive pulmonary disease severity and cardiovascular outcomes.
Curkendall SM; Lanes S; de Luise C; Stang MR; Jones JK; She D; Goehring E
Eur J Epidemiol; 2006; 21(11):803-13. PubMed ID: 17106760
[TBL] [Abstract][Full Text] [Related]
15. Incidence of GOLD-defined chronic obstructive pulmonary disease in a general adult population.
Johannessen A; Omenaas E; Bakke P; Gulsvik A
Int J Tuberc Lung Dis; 2005 Aug; 9(8):926-32. PubMed ID: 16104642
[TBL] [Abstract][Full Text] [Related]
16. Impact of chronic obstructive pulmonary disease on post-myocardial infarction outcomes.
Salisbury AC; Reid KJ; Spertus JA
Am J Cardiol; 2007 Mar; 99(5):636-41. PubMed ID: 17317363
[TBL] [Abstract][Full Text] [Related]
17. The risk of obstructive airways disease in a glaucoma population.
Huerta C; García Rodríguez LA; Möller CS; Arellano FM
Pharmacoepidemiol Drug Saf; 2001; 10(2):157-63. PubMed ID: 11499855
[TBL] [Abstract][Full Text] [Related]
18. Mortality risk in patients receiving drug regimens with theophylline for chronic obstructive pulmonary disease.
Lee TA; Schumock GT; Bartle B; Pickard AS
Pharmacotherapy; 2009 Sep; 29(9):1039-53. PubMed ID: 19698009
[TBL] [Abstract][Full Text] [Related]
19. Chronic obstructive pulmonary disease is missed in asthmatics in specialty care in Trinidad, West Indies.
Pinto Pereira LM; Bartholomew LA; Brooks H; Lowe D; Rocke K; Rolle S; Smith J; Thekwini O; Seemungal TA; Bekele I
Int J Tuberc Lung Dis; 2007 Sep; 11(9):1026-32. PubMed ID: 17705983
[TBL] [Abstract][Full Text] [Related]
20. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
